Last reviewed · How we verify

NCT05673408

NIBP Validation Study

Recruiting now Last updated 9 December 2025
What this trial tests

trial testing Philips IntelliVue X3 Patient Monitor in Critical Illness in 189 participants. Currently enrolling.

Timeline
23 June 2023
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorPhilips Clinical & Medical Affairs Global
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment189
Start date23 June 2023
Primary completion31 December 2026
Estimated completion31 December 2026
Sites5 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Philips Clinical & Medical Affairs Global — full company profile →

Who can join

Eligibility, any sex, with Critical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to compare measurements of blood pressure (BP) between the Philips non-invasive blood pressure (NIBP) system (including NIBP cuff and portable patient monitor) and invasive radial for Subject Group 2 and 3, and radial or umbilical arterial line for neonates (A-line) in critical care patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Critical Illness

Currently open trials in the same condition.

Other Philips Clinical & Medical Affairs Global trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05673408.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing